Omkar Pharmachem has announced the closure of its trading window for designated persons and their immediate relatives.

This precautionary measure will remain in effect until 48 hours following the declaration of the financial results for the quarter ended June 30, 2026. The company will soon announce the date of the crucial board meeting to consider and approve these forthcoming results.

This standard practice is implemented to maintain transparency and prevent any potential insider trading activity ahead of important financial disclosures, safeguarding investor interests.